p53r280k (Addgene inc)
Structured Review
P53r280k, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 43 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p53r280k/pLenti6%2FV5-p53_wt+p53+(Plasmid+%2322945)/bio_rxiv__64898__2026__01__12__698947-197-21-29
Average 93 stars, based on 43 article reviews
Images
Related Articles
Generated:Article Title: PROTAC-Driven Protective Therapy increases the therapeutic window of anticancer drugs Article Snippet: 2 days after transduction, cells were selected with 10□μg/mL of blasticidin S HCl (A1113903, Gibco) for 10 days. .. Lentiviral particles were generated with vectors encoding human p53 with a C-terminal V5 tag coding for WT p35, p53R175H, p53R249S, p53R273H, Control:Article Title: PROTAC-Driven Protective Therapy increases the therapeutic window of anticancer drugs Article Snippet: 2 days after transduction, cells were selected with 10□μg/mL of blasticidin S HCl (A1113903, Gibco) for 10 days. .. Lentiviral particles were generated with vectors encoding human p53 with a C-terminal V5 tag coding for WT p35, p53R175H, p53R249S, p53R273H, Plasmid Preparation:Article Title: PROTAC-Driven Protective Therapy increases the therapeutic window of anticancer drugs Article Snippet: 2 days after transduction, cells were selected with 10□μg/mL of blasticidin S HCl (A1113903, Gibco) for 10 days. .. Lentiviral particles were generated with vectors encoding human p53 with a C-terminal V5 tag coding for WT p35, p53R175H, p53R249S, p53R273H, |

